Type Ii Cells
Type Ii Cells - Related Videos
09:48
Separation of Spermatogenic Cell Types Using STA-PUT Velocity Sedimentation
0 Views •
Cited by 111 •
2013
The STA-PUT method allows for the separation of different populations of spermatogenic cells based on size and density.
01:24
T Cell Types and Functions
0 Views •
2024
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines. Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
08:53
Isolation and Transcriptome Analysis of Plant Cell Types
0 Views •
Cited by 2 •
2023
The feasibility and effectiveness of high-throughput scRNA-seq methods herald a single-cell era in plant research. Presented here is a robust and complete procedure for isolating specific Arabidopsis thaliana root cell types and subsequent transcriptome library construction and analysis.
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
0 Views •
2025
This protocol describes the in vivo reprogramming of mouse cancer cells into type 1 dendritic-like cells within the tumor microenvironment through enforced expression of the transcription factors PU.1, IRF8, and BATF3.
11:29
Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
0 Views •
Cited by 31 •
2016
In multicellular organisms, secreted soluble factors elicit responses from different cell types as a result of paracrine signaling. Insert co-culture systems offer a simple way to assess the changes mediated by secreted soluble factors in the absence of cell-cell contact.
FAQs
Surfactant reduces the surface tension at the air-liquid interface lining each alveolus. By lowering this force, it helps keep air sacs open rather than allowing them to collapse, supporting the architecture required for gas exchange. In engineered models, surfactant production can therefore indicate whether Type II cells retain a functionally relevant epithelial state.
Following injury, Type II cells can proliferate and contribute to epithelial repair. This regenerative behavior gives them significance beyond surfactant secretion, because their activity may help restore the cellular lining that supports air-sac function. Bioengineered systems can use this property to investigate how lung tissue responds to damage and begins the repair process.
Surfactant production provides a measurable indication that Type II cells are performing a central alveolar function. Because surfactant helps prevent collapse, its presence connects cellular activity with preservation of air-sac behavior. Researchers can use this feature when evaluating whether lung organoids or engineered tissue models reproduce relevant aspects of lung physiology.
Their ability to proliferate after injury makes Type II cells relevant to engineered systems focused on epithelial restoration. Models can examine both surfactant-related function and the contribution of these cells to repair, allowing researchers to study lung responses rather than only static tissue structure. This supports investigation of future regenerative therapies.
Type II cells are incorporated into lung organoids and engineered tissue models to reproduce selected aspects of alveolar biology. Their inclusion enables these systems to examine surfactant production, air-sac maintenance, and epithelial responses to injury. Such models provide a bioengineering setting for studying lung function without relying only on isolated cellular observations.
These models can be applied to questions involving lung development, injury, fibrosis, and responses to drugs. Type II cells add relevant functional and reparative behavior through surfactant secretion and epithelial recovery. Consequently, engineered lung systems can connect disease-related changes or treatment effects with alterations in alveolar cell activity.
Microfluidic respiratory systems provide an engineered platform in which Type II cell behavior can be examined as part of a lung-relevant model. Their use supports studies of lung function, injury, fibrosis, and drug responses. Observing surfactant production or repair-related activity in these systems helps evaluate how closely the model reflects important epithelial processes.